| Application no. and date | 06750475.3 (espacenet) (Federated) (European Patent Register), 20060418 | | Patent/reg. no. and date | DK/EP 1871347, 20160803 | | Publication date | 20080102 | | Priority no. and date | US 672805 P, 20050419 | | EP pub. no. and date |
EP 1871347 20080102 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/154118 | | Inventor | CARTER, Barry Howard,
GlaxoSmithKline Corp. Int., Five Moore Dr.,
P.O. Box 13398,
Res. Triagle Park
North Carolina 27709, US,
CAMPBELL, Dwayne A.,
GlaxoSmithKline Corp. Int., Five Moore Dr.,
P.O. Box 13398,
Res. Triagle Park
North Carolina 27709, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , C07D 405/04 (2006.01) | | Title | Farmaceutisk sammensætning | | Int. application no. | US2006014447 | | Int. publication no. | WO2006113649 | | Related patent (certificate) | | | Status | Afkaldt | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
